Company Filing History:
Years Active: 2012-2016
Title: The Innovations of Nam-Mew Pui
Introduction
Nam-Mew Pui is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on developing innovative solutions for various medical conditions.
Latest Patents
Among his latest patents is a long-acting dual release product containing carbinoxamine and pseudoephedrine. This invention provides oral dosage forms that contain carbinoxamine in an immediate release format, and pseudoephedrine in a prolonged release format. The biphasic oral dosage forms may also include other active ingredients in combination with carbinoxamine, such as other decongestants, antitussives, analgesics, and expectorants. Another significant patent is a method for ameliorating pruritus. This method aims to prevent, treat, or alleviate pruritus caused by skin, mucosa, or systemic disorders. It involves administering to a subject with pruritus or topically applying to an affected area an effective amount of a formulation consisting essentially of a phenylbutyric acid or short-chain fatty acid derivative and a pharmaceutically acceptable carrier, salt, or solvate thereof.
Career Highlights
Nam-Mew Pui has worked with reputable companies in the pharmaceutical industry, including Asan Laboratories Company and E5 Pharma, LLC. His experience in these organizations has contributed to his expertise in developing innovative medical products.
Collaborations
He has collaborated with notable coworkers such as Yih-Lin Chung and Wei-wei Chang, further enhancing his contributions to the field.
Conclusion
Nam-Mew Pui's innovative work in pharmaceuticals demonstrates his commitment to improving healthcare solutions. His patents reflect a deep understanding of medical needs and a dedication to advancing treatment options.